Balasa Dinverno & Foltz LLC Cvs Health Corp Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Cvs Health Corp stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 53,033 shares of CVS stock, worth $2.35 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

53,033

Previous 51,767 2.45%

Holding current value

$2.35 Million

Previous $4.8 Million 5.44%

% of portfolio

0.32%

Previous 0.3%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$92.53 - $106.43 $117,142 - $134,740	1,266 Added 2.45%	53,033 $5.06 Million
Q2 2022 Aug 09, 2022	SELL	$88.66 - $106.64 $476,281 - $572,870	-5,372 Reduced 9.4%	51,767 $4.8 Million
Q1 2022 Apr 25, 2022	BUY	$100.77 - $110.83 $287,698 - $316,419	2,855 Added 5.26%	57,139 $5.78 Million
Q4 2021 Jan 26, 2022	BUY	$83.15 - $103.7 $148,422 - $185,104	1,785 Added 3.4%	54,284 $5.6 Million
Q3 2021 Oct 26, 2021	BUY	$80.05 - $87.47 $276,973 - $302,646	3,460 Added 7.06%	52,499 $4.46 Million
Q2 2021 Jul 23, 2021	BUY	$73.79 - $89.81 $91,499 - $111,364	1,240 Added 2.59%	49,039 $4.09 Million
Q1 2021 Apr 29, 2021	BUY	$68.13 - $76.3 $93,678 - $104,912	1,375 Added 2.96%	47,799 $3.6 Million
Q4 2020 Jan 26, 2021	SELL	$55.93 - $74.5 $620,711 - $826,801	-11,098 Reduced 19.29%	46,424 $3.17 Million
Q3 2020 Nov 10, 2020	BUY	$56.71 - $65.71 $1.72 Million - $1.99 Million	30,335 Added 111.58%	57,522 $3.36 Million
Q2 2020 Aug 07, 2020	BUY	$55.41 - $70.62 $548,891 - $699,561	9,906 Added 57.32%	27,187 $1.77 Million
Q1 2020 Apr 30, 2020	BUY	$52.3 - $76.05 $216,260 - $314,466	4,135 Added 31.45%	17,281 $1.03 Million
Q4 2019 Jan 22, 2020	BUY	$60.38 - $76.58 $340,301 - $431,604	5,636 Added 75.05%	13,146 $977,000
Q3 2019 Nov 06, 2019	BUY	$54.09 - $64.3 $159,186 - $189,234	2,943 Added 64.44%	7,510 $474,000
Q2 2019 Aug 07, 2019	SELL	$52.13 - $57.33 $55,362 - $60,884	-1,062 Reduced 18.87%	4,567 $249,000
Q1 2019 May 10, 2019	SELL	$52.36 - $69.88 $223,524 - $298,317	-4,269 Reduced 43.13%	5,629 $304,000
Q4 2018 Feb 04, 2019	BUY	$62.92 - $80.8 $145,156 - $186,405	2,307 Added 30.39%	9,898 $649,000
Q3 2018 Oct 24, 2018	BUY	$63.78 - $79.59 $80,745 - $100,760	1,266 Added 20.02%	7,591 $598,000
Q2 2018 Aug 01, 2018	SELL	$60.71 - $72.18 $60,710 - $72,180	-1,000 Reduced 13.65%	6,325 $407,000
Q1 2018 Apr 23, 2018	BUY	$60.6 - $83.63 $2,060 - $2,843	34 Added 0.47%	7,325 $456,000
Q4 2017 Feb 05, 2018	SELL	$66.8 - $80.91 $34,535 - $41,830	-517 Reduced 6.62%	7,291 $529,000
Q3 2017 Oct 18, 2017	BUY	$75.35 - $83.31 $588,332 - $650,484	7,808	7,808 $635,000

Others Institutions Holding CVS

# of Institutions

2,109

Shares Held

973M

Call Options Held

24.9M

Put Options Held

20.2M

View Full List

About CVS HEALTH Corp

Ticker CVS
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 1,312,829,952
Market Cap $58.1B
Description
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...

More about CVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Cvs Health Corp Transaction History